BMY
$59.28 · +4.6% today · −0.7% 5d · −1.0% 3m · +42.2% 1y
Daily score42
Weekly score54
Long-term score84
Close
Scores (0–100)
Components — latest (2026-10-14)
Close
59.28
1D return
+4.6%
5D return
−0.7%
Rel volume
0.97
CMF 20
0.05
OBV slope 20
-0.18
Up-vol ratio 10
0.33
Short ratio
0.44
Short ratio Δ
−5.0%
Persistence 10
1.00
Inflow mean 5d
-0.03
Inflow mean 60d
0.53
Momentum 12-1
+51.3%
% of 52w high
+88.0%
vs 200d
+1.5%
Volatility 60d
+25.3%
Dollar vol 20d
$893.35M
Insider buys 90d
$0
Insider buyers 90d
0.00
Revenue growth
+5.7%
Fundamentals — Bristol Myers Squibb · Health Care
as of 2026-10-22- P/E
- 18.2
- P/B
- 5.77
- ROE
- 31.6%
- Operating margin
- —
- Debt / equity
- 1.89
- FCF yield
- 10.0%
- Years profitable
- 4/5
- BM score
- 85
- Moat flag
- No
Insider trades (Form 4)
| Filed | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-09-10 | Massacesi Cristian | EVP,Chief Med Offr,Head of Dev | Sell | 6.2K | $64.57 | $403.5K |
| 2026-08-26 | Holzer Phil M | SVP and Controller | Sell | 500 | $67.50 | $33.8K |
Congress trades
| Filed | Traded | Member | Type | Owner | Amount | Lag | Source |
|---|---|---|---|---|---|---|---|
| 2026-06-11 | 2026-05-07 | Mike Kelly (PA16) | Sale | Self | $15,001 - $50,000 | 35 | |
| 2026-01-12 | 2025-12-19 | Gilbert Cisneros (CA31) | Purchase | Self | $1,001 - $15,000 | 24 | |
| 2026-01-15 | 2025-12-18 | Julie Johnson (TX32) | Sale | Joint | $1,001 - $15,000 | 28 | |
| 2025-12-11 | 2025-11-13 | Julie Johnson (TX32) | Sale (partial) | Joint | $1,001 - $15,000 | 28 | |
| 2025-12-15 | 2025-11-12 | Gilbert Cisneros (CA31) | Purchase | Self | $1,001 - $15,000 | 33 | |
| 2025-11-18 | 2025-10-09 | Gilbert Cisneros (CA31) | Sale (partial) | Self | $1,001 - $15,000 | 40 | |
| 2026-01-13 | 2025-04-28 | Julia Letlow (LA05) | Sale | Self | $1,001 - $15,000 | 260 | |
| 2026-01-13 | 2024-10-23 | Julia Letlow (LA05) | Purchase | Self | $1,001 - $15,000 | 447 |
Source: U.S. House Clerk periodic transaction reports (STOCK Act). Disclosures lag trades.